Mark Wright

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study

Eleonora Scorletti, Lokpal Bhatia, Keith McCormick et al. · Hepatology · 2014 · 310 citations

Medicine, Nutritional Sciences, Pharmacology +17

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease

Eleonora Scorletti, Paul R. Afolabi, Elizabeth A. Miles et al. · Gastroenterology · 2020 · 221 citations · Full text

Life Sciences, Microbiology, Microbial Ecology +14

Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR

Sylvia Knapp, Leland J. Yee, A J Frodsham et al. · Genes and Immunity · 2003 · 220 citations

Life Sciences, Genetics, Molecular Genetics +14

In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA

Nikhil Vergis, Stephen R. Atkinson, Suzanne Knapp et al. · Gastroenterology · 2016 · 189 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Association of Genetic Variants of the Chemokine Receptor Ccr5 and Its Ligands, Rantes and Mcp–2, With Outcome of Hcv Infection

Simon Hellier, A J Frodsham, Branwen J. Hennig et al. · Hepatology · 2003 · 183 citations

Life Sciences, Genetics, Immunology +17